Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Saints or Saviors? Secondary Buyers Offer Exit for BSX, Others

This article was originally published in Start Up

Executive Summary

Following the sale of Boston Scientific's venture portfolio, secondary buyers are positioning themselves as possible purchases of venture capital portfolios.

Related Content

Will Rise of Corporate Investors Lead to Return of Device Returns?
Asthmatx Acquisition By Boston Scientific Is Source of Many Happy Returns
Secondary Directs: Tonic for the Biotech Venture Financing Model?
A New Chapter for Device VCs
Late Stage Device Financing Comes with a Price, Some Pain
The Top Device Stories of 2008
Emphysema: Elusive Target for Device Companies
Best of the IN VIVO Blog (11/2008)
Device VCs not Immune to Crisis
Boston Scientific Shuffles and Sells in Bid to Right Ship


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts